Skip to main content
UHSUniversal Health Services, Inc.Sell6.2·$163.29-2.90%
SellModerate Confidence
Investment thesis

Universal Health Services trades at a forward P/E of just 5.8x with a reward-to-risk ratio of 7.89 and 33% analyst upside, offering deep value relative to healthcare facility peers, though confirmed downtrend momentum and an elevated put/call ratio of 2.17 create near-term headwinds.

Thesis pillars

  • Deep Value Forward Pe At 5xDeteriorating
  • Strong Earnings Beat With Analyst UpsideDeteriorating
  • Confirmed Downtrend Death Cross BlockImproving
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Universal Health Services, Inc. (UHS) Stock Analysis

Recovery setup

SellValueQualityModerate Confidence

Healthcare · Medical Care Facilities

Sell if holding. At $163.29, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Consecutive earnings misses (2); Below 200-MA, MA slope -3.2%/30d (confirmed downtrend).

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from... Read more

$163.29+12.6% A.UpsideScore 6.2/10#7 of 36 Medical Care Facilities
QualityF-score8 / 9FCF yield4.89%
IncomeYield0.48%(5y avg 0.51%)Payout3.27%sustainable
Stop $151.86Target $183.81(analyst − 10%)A.R:R 1.0:1
Analyst target$204.24+25.1%17 analysts
$183.81our TP
$163.29price
$204.24mean
$310

Sell if holding. At $163.29, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Consecutive earnings misses (2); Below 200-MA, MA slope -3.2%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 58. Score 6.2/10, moderate confidence.

Passes 5/8 gates (positive momentum, clean insider activity, earnings proximity 88d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Mon, Oct 26, 202688d to earnings· next earnings call

Thesis

Rewards
Attractive valuation
Positive momentum
Positive insider activity
Risks
Consecutive earnings misses (2)
Below 200-MA, MA slope -3.2%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)6.8
P/E (Fwd)6.9
Mkt Cap$10.2B
EV/EBITDA5.7
Profit Mgn8.4%
ROE20.9%
Rev Growth8.3%
Beta1.07
Dividend0.48%
Rating analysts26

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C1.87bearish
IV39%normal

Concentration Risks(10-K Item 1A)

  • LOWGeographicNevada17%
    10-K Item 1A: 'Nevada: We own 10 inpatient acute care hospitals ... these facilities contributed 17% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicTexas16%
    10-K Item 1A: 'Texas: We own 7 inpatient acute care hospitals ... these facilities contributed 16% of our consolidated net revenues during each of 2025 and 2024'
  • LOWGeographicCalifornia11%
    10-K Item 1A: 'California: We own 5 inpatient acute care hospitals ... these facilities contributed 11% of our consolidated net revenues during each of 2025 and 2024'

Material Events(8-K, last 90d)

  • 2026-05-21Item 5.02MEDIUM
    Matthew J. Peterson, EVP and President, Behavioral Health, resigned effective June 19, 2026, to pursue an external career opportunity. CEO Marc D. Miller assumes interim responsibilities for the Behavioral Health Care Division; search for permanent replacement underway. No disagreement cited.
    SEC filing →
  • 2026-03-30Item 5.02LOW
    Compensation Committee approved 2026 annual incentive bonus formulae for executive officers and a $1.07 million discretionary cash bonus for Executive Chairman Alan B. Miller for 2025. Routine compensatory arrangement; no departure or appointment.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
1.8
Support Resistance
2.4
52w Position
3.3
Gap
6.0
GatesA.R:R 1.0 < 1.5@spotDeath cross (50MA < 200MA)Executive change: officer departure/appointmentMomentum 7.3>=5.5Insider activity: OKEARNINGS PROXIMITY 88d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
58 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $142.38Resistance $170.00

Price Targets

$152
$184
A.Upside+12.6%
A.R:R1.0:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! NEWS_MOD=-1: HOLD_IF_HOLDING → SELL_IF_HOLDING
! asymmetry at 1.0 (below the engine's 1.5 threshold)@spot

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-10-26 (88d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is UHS stock a buy right now?

Sell if holding. At $163.29, A.R:R 1.0:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Consecutive earnings misses (2); Below 200-MA, MA slope -3.2%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 58. Prior stop was $151.86. Score 6.2/10, moderate confidence.

What is the UHS stock price target?

Take-profit target: $183.81 (+12.6% upside). Prior stop was $151.86. Stop-loss: $151.86.

What are the risks of investing in UHS?

Consecutive earnings misses (2); Below 200-MA, MA slope -3.2%/30d (confirmed downtrend).

Is UHS overvalued or undervalued?

Universal Health Services, Inc. trades at a P/E of 6.8 (forward 6.9). TrendMatrix value score: 8.2/10. Verdict: Sell.

What do analysts say about UHS?

26 analysts cover UHS with a consensus score of 3.5/5. Average price target: $204.

What does Universal Health Services, Inc. do?Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers...

Universal Health Services owns and operates acute care hospitals, behavioral health facilities, and outpatient centers across 40 states, Washington D.C., the United Kingdom, and Puerto Rico, with 375 inpatient and 168 outpatient facilities as of February 2026. Revenue comes from Medicare, Medicaid, and private insurers, with acute care generating approximately 57% of consolidated net revenues and behavioral health approximately 43%; U.K. operations contributed approximately $1.0 billion in 2025.

Related stocks: THC (Tenet Healthcare Corporation) · ARDT (Ardent Health, Inc.) · ASTH (Astrana Health Inc.) · EHC (Encompass Health Corporation) · HCA (HCA Healthcare, Inc.)
Home Stocks UHS

Latest news

Latest News

Benzinga7h agoCONCERNAnalyst
Benzinga1d agoCONCERNEarnings
Yahoo Finance9d agoEarnings
GuruFocus9d ago
Yahoo Finance100d ago
Yahoo Finance100d agoEarnings
TradingKey44d ago
AD HOC NEWS44d agoAnalyst
Sahm50d ago
Marketscreener.com9d ago
TipRanks9d ago
The Globe and Mail100d agoEarnings
TradingView100d agoEarnings
AD HOC NEWS44d agoEarnings
AD HOC NEWS45d ago
GuruFocus16d ago
Yahoo Finance16d ago
Smartkarma16d ago
Quiver Quantitative16d ago
Yahoo Finance51d ago
Loading more...